They are disposable medical materials that need to be withdrawn from the body with the catheter at the end of the intervention and do not need to stay in the body for a long time, and therefore do not need to be validated in long-term clinical trials. Since interventions are mostly minimally invasive, the catheters used (e.g., guiding catheters, balloon catheters, etc.) are mostly soft plastics with very fine diameters, and therefore require very small sizes (millimeters or microns), very thin thicknesses (mostly tens of microns), very high dimensional accuracy, and good surface finish and plasticity, so the processing of the rings is very difficult.

Due to its very good corrosion resistance, oxidation resistance, wear resistance, high temperature creep resistance and other properties, the platinum-iridium alloy is defined as a natural high-temperature alloy, with its good development, biocompatibility, stable physical and chemical properties to become the preferred material for development rings. Our company prepares the platinum-iridium alloy with uniform composition and high density by melting, and then processes it into microfine tubes with outer diameter and wall thickness that meet the dimensional requirements through drilling and multi-step hot rolling, cold rolling and drawing processes. Then the tubes are cut according to the application and size requirements to obtain the platinum-iridium alloy ring, the whole process of independent production, to ensure that the whole industry chain control!

After that, MOOSEN Bio will carry out further technology development of platinum-iridium alloy developer ring, overcome the platinum-iridium alloy homogeneous melting technology, hot/cold rolling of tubes, capillary tube drawing technology, developer ring cutting technology and surface treatment technology, and strive to obtain high quality platinum-iridium alloy developer ring, establish batch production line, and become a global famous medical material brand!